jRCT1051180028已完成不适用
Induction Chemotherapy and Adjuvant Thoracic Radiation in Resectable Stage N2-3A/3B Non-small Cell Lung Cancer (ICAT in N2-3A/3B NSCLC)
未提供0 个研究点目标入组 25 人开始时间: 2019年3月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 25
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 75age old not（—）
- 性别
- All
入选标准
- •c-stage 3A/3B with pathologically diagnosed N2 without chest wall invasion
- •2.Resectable following induction chemotherapy
- •3.Normal pulmonary function within 56days before IC
- •4.No previous chemotherapy or thoracic radiation
- •5.age 20-75 years at IC
- •6.ECOG Performance Status0-1
- •7.Normal bone marrow, liver, and renal function below within 28days before IC
- •8.Written informed consent was obtained
排除标准
- •1.Unresectable extra-nodal mediastinal lymph node in CT
- •2.Contraindication for CBDCA or nab-PTX
- •3.Past history of severe drug allergy
- •4.Pulmonary dysfunction
- •5.Myocardial infarction within 180 days before IC
- •6.Interstitial pneumonia or pulmonary fibrosis detected in CT 56days before IC
- •7.Medication with PSL more than 10mg/day 90days before IC
- •8.Clinically relevant heart disease
- •9.Clinically relevant psychological disorder
- •10.Uncontrollable DM
- •11.Clinically relevant infection disease
- •12.Other clinically relevant comorbidity
- •13.Active double cancer
- •14.Pregnant, lactating, possibly pregnant
- •15.Inappropriate by investigator
结局指标
主要结局
-
Treatment completion
次要结局
未报告次要终点
研究者
相似试验
招募中
3 期
Comparison of one vs three week radiation for breast cancerCTRI/2021/09/036622AIIMS
进行中（未招募）
不适用
Concurrent chemoradiotherapy for stage III non small cell lung cancer followed by consolidation pemetrexed: a phase II study - CONCEPTon-small cell lung cancer, stage IIIMedDRA version: 9.1Level: LLTClassification code 10029520Term: Non-small cell lung cancer stage IIIAMedDRA version: 9.1Level: LLTClassification code 10029521Term: Non-small cell lung cancer stage IIIBEUCTR2006-005566-39-GBChristie Hospital NHS Foundation Trust35
已完成
3 期
Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate CancerProstate CancerNCT00394511National Cancer Institute (NCI)408
尚未招募
3 期
Chemoradiotherapy versus Radiotherapy alone in post-operative locally advanced oral cavity cancerCTRI/2024/06/069157Department Of Radiotherapy and Radiation medicine
招募中
3 期
A phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil (DCF) vs definitive chemoradiotherapy for locally advanced unresectable squamous cell carcinoma of the thoracic esophagus(JCOG1510,TRIANgLE)locally advanced unresectable squamous cell carcinoma of the thoracic esophagusJPRN-UMIN000031165Japan Clinical Oncology Group (JCOG)230